The use of cell saver with intraoperative autologous blood transfusion is not related to worsened oncologic outcomes in patients with viable hepatocellular carcinoma

dc.contributor.author	Giampaoli, Angelo Zanin D'angelo	pt_BR
dc.contributor.author	Lopes, Bruno de Brito	pt_BR
dc.contributor.author	Chedid, Márcio Fernandes	pt_BR
dc.contributor.author	Pinto, Marcelo de Abreu	pt_BR
dc.contributor.author	Chedid, Aljamir Duarte	pt_BR
dc.contributor.author	Grezzana Filho, Tomáz de Jesus Maria	pt_BR
dc.contributor.author	Leipnitz, Ian	pt_BR
dc.contributor.author	Álvares-da-Silva, Mário Reis	pt_BR
dc.contributor.author	Prediger, João Edson	pt_BR
dc.contributor.author	Zahler, Sofia	pt_BR
dc.date.accessioned	2021-07-15T04:31:17Z	pt_BR
dc.date.issued	2020	pt_BR
dc.identifier.uri	http://hdl.handle.net/10183/223929	pt_BR
dc.format.mimetype	application/pdf	pt_BR
dc.language.iso	eng	pt_BR
dc.relation.ispartof	Clinical and biomedical research. Porto Alegre	pt_BR
dc.rights	Open Access	en
dc.subject	Medicina	pt_BR
dc.title	The use of cell saver with intraoperative autologous blood transfusion is not related to worsened oncologic outcomes in patients with viable hepatocellular carcinoma	pt_BR
dc.type	Resumo publicado em evento	pt_BR
dc.contributor.event	Hospital de Clínicas de Porto Alegre. Semana Científica. (40. : 2020 : Porto Alegre, RS)	pt_BR
dc.identifier.nrb	001128336	pt_BR
dc.type.origin	Nacional	pt_BR

Este item está licenciado na Creative Commons License